Calpastatin-modulation of m-calpain activity is required for myoblast fusion

European Journal of Cell Biology

Volumn 75, Issue 3, 1998, Pages 247-253

  Balcerzak, Denis ^a   Cottin, Patrick ^a   Poussard, Sylvie ^a   Cucuron, Aurélie ^a   Brustis, Jean J ^a   Ducastaing, André ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Antisense oligodeoxyribonucleotides; Calpain; Calpastatin; Culture in vitro; Myoblast fusion

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CALPAIN; CALPASTATIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUSION; EMBRYO; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031946590     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-9335(98)80120-9     Document Type: Article

References (31)

1. Balcerzak, D., S. Poussard, J. J. Brustis, N. Elamrani, M. Soriano, P. Cottin, A. Ducastaing: An antisense oligodeoxyribonucleotide to m-calpain mRNA inhibits myoblast fusion. J. Cell Sci. 108, 2077-2082 (1995).
2. Barnoy, S., T. Glaser, N. S. Kosower: The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion. Biochem. Biophys. Res. Commun. 220, 933-938 (1996).
3. Brustis, J. J., N. Elamrani, D. Balcerzak, A. Safwate, M. Soriano, S. Poussard, P. Cottin, A. Ducastaing: Rat myoblast differentiation requires exteriorized m-calpain activity. Eur. J. Cell Biol. 64, 320-327 (1994).
4. Chomczynski, P., N. Sacchi: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
5. 2+-dependent proteases (calpains) and muscle cell differentiation. Biochim. Biophys. Acta 1223, 170-178 (1994).
6. Croall, D. E., G. N. DeMartino: Calcium-activated neutral protease (calpain) system: structure, function and regulation. Physiol. Rev. 71 (3), 813-847 (1991).
7. Debus, E., K. Weber, M. Osborn: Monoclonal antibodies to desmin, the muscle-specific intermediate filament protein. EMBO J. 12, 2305-2312 (1983).
8. Endo, T., B. Nadal-Ginar: Three types of muscle-specific gene expression in fusion-blocked rat skeletal muscle cells: translational control in EGTA-treated cells. Cell 49, 515-526 (1987).
9. Glaser, T., N. S. Kosower: Fusibility of erythrocytes is determined by a protease-protease inhibitor (calpain-calpastatin) balance. FEBS Lett. 206, 115-120 (1986).
10. Ishida, S., Y. Emori, K. Suzuki: Rat calpastatin has diverged primary sequence from other mammalian calpastatin but retains functionally important sequences. Biochim. Biophys. Acta 1083 (3), 436-438 (1991).
11. Koenig, J.: Formation and maturation of nerve-muscle contacts in cultured rat embryo cell. Biol. Cell. 35, 147-152 (1979).
12. 2+-dependent proteolysis. pp. 163-181. CRC Press. Boca Raton, FL 1990.
13. Kosower, N. S., T. Glaser, E. M. Kosower: Membrane-mobility agent-promoted fusion of erythrocytes: fusibility is correlated with attack by calcium-activated cytoplasmic proteases on membrane proteins. Proc. Natl. Acad. Sci. USA 80, 7542-7546 (1983).
14. Kosower, E. M., N. S. Kosower, P. Wegman: Membrane mobility agents IV. The mechanism of particle-cell and cell-cell fusion. Biochim. Biophys. Acta 471, 311-329 (1977).
15. Kwak, K. B., S. S. Chung, O. M. Kim, M. S. Kang, D. B. Ha, C. H. Chung: Increase in the level of m-calpain correlates with the elevated cleavage of filamin during myogenic differentiation of embryonic muscle cells. Biochim. Biophys. Acta 1175, 243-249 (1993).
16. Laemmli, U. K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685 (1970).
17. Lowry, O. H., N. J. Rosebrough, A. L. Farr, R. J. Randall: Protein measurement with the Folin Phenol reagent. J. Biol. Chem. 193, 265-268 (1951).
18. Massague, J., S. Cheifetz, T. Endo, B. Nadal-Ginard: Type β-transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 83, 8206-8210 (1986).
19. Mellgren, R. L.: Calcium-dependent proteases: an enzyme system active at cellular membranes. FASEB J. 1, 110-115 (1987).
20. 2+-dependent protease (calpain) and its high molecular weight endogenous inhibitor (calpastatin). Adv. Enzyme Regul. 19, 407-424 (1981).
21. Olson, E. N.: Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154, 261-272 (1992).
22. Paw, P. G., J. D. Davis: Alterations in surface proteins during myogenesis of a rat myoblast cell line. Dev. Biol. 70, 27-38 (1979).
23. Poussard, S., P. Cottin, J. J. Brustis, S. Talmat, N. Elamrani, A. Ducastaing: Quantitative measurement of calpain I and calpain II mRNAs in differentiating rat muscle cells using a competitive polymerase chain reaction. Biochimie 75, 885-890 (1993).
24. Rawis, A., E. Olson: Myo D meets its maker. Cell 89, 5-8 (1997).
25. Saïdo, T. C., H. Sorimachi, K. Suzuki: Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8, 814-822 (1994).
26. 2+-activated protease in myoblast fusion. Exp. Cell Res. 162, 411-422 (1986).
27. Schollmeyer, J. E.: Possible role of calpain I and calpain II in differentiating muscle. Exp. Cell Res. 163, 413-422 (1986).
28. Sorirnachi, H., T. Saido, K. Suzuki: New area of calpain research. FEBS Lett. 343, 1-5 (1994).
29. Takano, E., N. Yumoto, R. Kannagi, T. Murachi: Molecular diversity of calpastatin in mammalian organs. Biochem. Biophys. Res. Commun. 122, 912-917 (1984).
30. Twinning, S. S.: Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes. Anal. Biochem. 143, 30-34 (1984).
31. Zhang, W., R. D. Lane, R. L. Mellgren: The major calpain isoenzymes are long-lived proteins. J. Biol. Chem. 271 (3), 18825-18830 (1996).